24
Participants
Start Date
October 31, 2009
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Regorafenib (Stivarga, BAY73-4506)
A single dose of regorafenib will be administered immediately following a high fat breakfast
Regorafenib (Stivarga, BAY73-4506)
A single dose of regorafenib will be administered immediately following a low fat breakfast
Regorafenib (Stivarga, BAY73-4506)
A single dose of regorafenib will be administered following an overnight fast
Brighton
Lead Sponsor
Bayer
INDUSTRY